1. Home
  2. FPH vs VERV Comparison

FPH vs VERV Comparison

Compare FPH & VERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FPH
  • VERV
  • Stock Information
  • Founded
  • FPH 2009
  • VERV 2018
  • Country
  • FPH United States
  • VERV United States
  • Employees
  • FPH N/A
  • VERV N/A
  • Industry
  • FPH Real Estate
  • VERV Medicinal Chemicals and Botanical Products
  • Sector
  • FPH Finance
  • VERV Health Care
  • Exchange
  • FPH Nasdaq
  • VERV Nasdaq
  • Market Cap
  • FPH 340.3M
  • VERV 384.2M
  • IPO Year
  • FPH 2017
  • VERV 2021
  • Fundamental
  • Price
  • FPH $5.43
  • VERV $4.80
  • Analyst Decision
  • FPH
  • VERV Strong Buy
  • Analyst Count
  • FPH 0
  • VERV 6
  • Target Price
  • FPH N/A
  • VERV $25.75
  • AVG Volume (30 Days)
  • FPH 129.2K
  • VERV 2.9M
  • Earning Date
  • FPH 07-17-2025
  • VERV 05-14-2025
  • Dividend Yield
  • FPH N/A
  • VERV N/A
  • EPS Growth
  • FPH 69.50
  • VERV N/A
  • EPS
  • FPH 1.24
  • VERV N/A
  • Revenue
  • FPH $241,148,000.00
  • VERV $59,613,000.00
  • Revenue This Year
  • FPH N/A
  • VERV $6.18
  • Revenue Next Year
  • FPH N/A
  • VERV N/A
  • P/E Ratio
  • FPH $4.39
  • VERV N/A
  • Revenue Growth
  • FPH 11.66
  • VERV 271.44
  • 52 Week Low
  • FPH $2.88
  • VERV $2.87
  • 52 Week High
  • FPH $6.71
  • VERV $9.31
  • Technical
  • Relative Strength Index (RSI)
  • FPH 50.26
  • VERV 53.54
  • Support Level
  • FPH $5.36
  • VERV $3.89
  • Resistance Level
  • FPH $5.64
  • VERV $4.63
  • Average True Range (ATR)
  • FPH 0.18
  • VERV 0.42
  • MACD
  • FPH -0.02
  • VERV 0.05
  • Stochastic Oscillator
  • FPH 15.09
  • VERV 74.79

About FPH Five Point Holdings LLC

Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational, and recreational elements, as well as civic areas, parks, and open spaces. Its three reportable segments are Valencia, San Francisco, and Great Park. It derives the majority of revenue from the Great Park segment which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.

About VERV Verve Therapeutics Inc.

Verve Therapeutics Inc clinical-stage company developing a new class of genetic medicines for cardiovascular disease, or CVD, with the potential to transform treatment from chronic therapies to single-course gene editing medicines. The current paradigm of chronic care is fragile requiring rigorous patient adherence, extensive healthcare infrastructure, and regular healthcare access, and leaves many patients without adequate care. Its pipelines are PCSK9, ANGPTL3, and LPA. The group has one reportable segment relating to the research and development of gene-editing medicines. The segment derives its current revenues from research and development collaborations.

Share on Social Networks: